Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...

Podrobná bibliografie
Hlavní autoři:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Médium:	Journal article
Jazyk:	English
Vydáno:	Wiley 2021

Podobné jednotky

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Autor: Xu, S, a další
Vydáno: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Autor: Wamil, M, a další
Vydáno: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
Autor: Leal, J, a další
Vydáno: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
Autor: Califf, R, a další
Vydáno: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
Autor: Currie, G, a další
Vydáno: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
Autor: Liam Mc Morrow, a další
Vydáno: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
Autor: M. N. Mamedov
Vydáno: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Autor: Holman, R, a další
Vydáno: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
Autor: Yates, T, a další
Vydáno: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
Autor: Yates, T, a další
Vydáno: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
Autor: Wamil, M, a další
Vydáno: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
Autor: Susanne Andersson, a další
Vydáno: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
Autor: Nihar Ranjan Mohanty, a další
Vydáno: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
Autor: Wamil, M, a další
Vydáno: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Autor: Farrer, M, a další
Vydáno: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
Autor: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Vydáno: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Autor: Preiss, D, a další
Vydáno: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
Autor: Califf, R, a další
Vydáno: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
Autor: Holman, R
Vydáno: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
Autor: Yutaka Inoue, a další
Vydáno: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
Autor: Page, R, a další
Vydáno: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
Autor: Ursula Mager, a další
Vydáno: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
Autor: Xin Zhang, a další
Vydáno: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
Autor: Anke Tönjes, a další
Vydáno: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
Autor: Huibin Huang, a další
Vydáno: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Autor: Gerstein, H, a další
Vydáno: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
Autor: Preiss, D, a další
Vydáno: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
Autor: Zhen Yang, a další
Vydáno: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
Autor: Dos Santos, M, a další
Vydáno: (2017)

Impaired glucose tolerance in sleep disorders.
Autor: Marietta Keckeis, a další
Vydáno: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
Autor: Stevens, R, a další
Vydáno: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
Autor: Brkić Milena, a další
Vydáno: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
Autor: Yupu Liu, a další
Vydáno: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Autor: Mostafa, SA, a další
Vydáno: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
Autor: Mc Morrow, L, a další
Vydáno: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
Autor: Lu Yu, a další
Vydáno: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
Autor: Marilia Harumi Higuchi dos Santos, a další
Vydáno: (2017-01-01)

List of people who have paid
Autor: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Autor: Latini, R, a další
Vydáno: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Autor: Sharma, A, a další
Vydáno: (2016)